INBS
Intelligent Bio Solutions Inc.
$2.36
+3.06%
2026-05-08
About Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc., a medical technology company, focused on developing and delivering non-invasive testing, and screening solutions in Asia Pacific, the United States, the United Kingdom, and internationally. The company operates intelligent fingerprinting drug screening system, a platform to analyze fingerprint sweat analysis to detect drugs abuse; and biosensor platform. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. Intelligent Bio Solutions Inc. was incorporated in 2016 and is headquartered in New York, New York.
Key Fundamentals
Forward P/E
6.69
EPS (TTM)
$-14.45
ROE
-150.2%
Revenue Growth (YoY)
47.6%
Profit Margin
0.0%
Debt/Equity
17.67
Price/Book
0.26
Beta
4.24
Market Cap
$5.1M
Avg Volume (10D)
42K
Recent Breakout Signals
No recent breakout signals detected for INBS.
Recent Price Range (60 Days)
60D High
$5.31
60D Low
$2.27
Avg Volume
95K
Latest Close
$2.36
Get breakout alerts for INBS
Sign up for Breakout Scanner to receive daily notifications when INBS triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Intelligent Bio Solutions Inc. (INBS) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors INBS daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. INBS operates in the Healthcare sector within the Medical Devices industry. Data is provided for informational purposes only and does not constitute financial advice.